JERAYGO DIN 02563983
Health Canada record
| Active ingredient(s) | APROCITENTAN 12.5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C02KN01 APROCITENTAN |
| Original market date | |
| Current status date | 24-Dec-2025 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing APROCITENTAN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02563991 | JERAYGO | IDORSIA PHARMACEUTICALS LTD | Tablet | APROCITENTAN 25 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36630 | 2025-12-23 | New Drug Submission (NDS) |